File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019

TitleTrends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019
Authors
Keywordscompeting risk analysis
disparity
epidemiology
second primary cancer
SEER
Issue Date8-Dec-2023
PublisherWiley
Citation
Cancer Medicine, 2023, v. 12, n. 24, p. 22316-22324 How to Cite?
AbstractBackground: Despite the growth in primary cancer (PC) survivors, the trends and disparities in this population have yet to be comprehensively examined using competing risk analysis. The objective is to examine trends in time to second primary cancer (SPC) and to characterize age, sex, and racial disparities in time-to-SPC. Methods: A retrospective analysis was conducted based on Surveillance, Epidemiology, and End Results (SEER). Two datasets for this study are (1) the discovery dataset with patients from SEER-8 (1990–2019) and (2) the validation dataset with patients from SEER-17 (2000–2019), excluding those in the discovery dataset. Patients were survivors of lung, colorectal, breast (female only), and prostate PCs. Results: The 5-year SPC cumulative incidences of lung PC increased from 1990 to 2019, with the cumulative incidence ratio being 1.73 (95% confidence intervals [CI], 1.64–1.82; p < 0.001). Age disparities among all PCs remained from 2010 to 2019, and the adjusted HRs (aHRs) of all PCs were above 1.43 when those below 65 were compared with those 65 and above. Sex disparity exists among colorectal and lung PC survivors. Racial disparities existed among non-Hispanic (NH) Black breast PC survivors (aHR: 1.11; 95% CI: 1.07–1.17; p < 0.001). The types of SPC vary according to PC and sex. Conclusions: Over the past three decades, there has been a noticeably shortened time-to-SPC among lung PC survivors. This is likely attributed to the reduced number of lung cancer deaths due to advancements in effective treatments. However, disparities in age, sex, and race still exist, indicating that further effort is needed to close the gap.
Persistent Identifierhttp://hdl.handle.net/10722/346449
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 1.174

 

DC FieldValueLanguage
dc.contributor.authorLeung, Tiffany H-
dc.contributor.authorEl Helali, Aya-
dc.contributor.authorWang, Xiaofei-
dc.contributor.authorHo, James C-
dc.contributor.authorPang, Herbert-
dc.date.accessioned2024-09-17T00:30:39Z-
dc.date.available2024-09-17T00:30:39Z-
dc.date.issued2023-12-08-
dc.identifier.citationCancer Medicine, 2023, v. 12, n. 24, p. 22316-22324-
dc.identifier.issn2045-7634-
dc.identifier.urihttp://hdl.handle.net/10722/346449-
dc.description.abstractBackground: Despite the growth in primary cancer (PC) survivors, the trends and disparities in this population have yet to be comprehensively examined using competing risk analysis. The objective is to examine trends in time to second primary cancer (SPC) and to characterize age, sex, and racial disparities in time-to-SPC. Methods: A retrospective analysis was conducted based on Surveillance, Epidemiology, and End Results (SEER). Two datasets for this study are (1) the discovery dataset with patients from SEER-8 (1990–2019) and (2) the validation dataset with patients from SEER-17 (2000–2019), excluding those in the discovery dataset. Patients were survivors of lung, colorectal, breast (female only), and prostate PCs. Results: The 5-year SPC cumulative incidences of lung PC increased from 1990 to 2019, with the cumulative incidence ratio being 1.73 (95% confidence intervals [CI], 1.64–1.82; p < 0.001). Age disparities among all PCs remained from 2010 to 2019, and the adjusted HRs (aHRs) of all PCs were above 1.43 when those below 65 were compared with those 65 and above. Sex disparity exists among colorectal and lung PC survivors. Racial disparities existed among non-Hispanic (NH) Black breast PC survivors (aHR: 1.11; 95% CI: 1.07–1.17; p < 0.001). The types of SPC vary according to PC and sex. Conclusions: Over the past three decades, there has been a noticeably shortened time-to-SPC among lung PC survivors. This is likely attributed to the reduced number of lung cancer deaths due to advancements in effective treatments. However, disparities in age, sex, and race still exist, indicating that further effort is needed to close the gap.-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofCancer Medicine-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectcompeting risk analysis-
dc.subjectdisparity-
dc.subjectepidemiology-
dc.subjectsecond primary cancer-
dc.subjectSEER-
dc.titleTrends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019-
dc.typeArticle-
dc.identifier.doi10.1002/cam4.6785-
dc.identifier.pmid38063337-
dc.identifier.scopuseid_2-s2.0-85179371862-
dc.identifier.volume12-
dc.identifier.issue24-
dc.identifier.spage22316-
dc.identifier.epage22324-
dc.identifier.eissn2045-7634-
dc.identifier.issnl2045-7634-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats